What is the TC chemo regimen and how does it treat breast cancer?

Q: What is the TC chemo regimen and how does it treat breast cancer?

TC is a chemotherapy regimen that combines Taxotere with cyclophosphamide and can be used before or after surgery to treat early-stage or localized breast cancer (breast cancer that hasn’t spread). Combination chemotherapy, such as TC, usually works better than individual drugs because each agent works in a different way to kill cancer cells and reduce cancer spread.

Medically reviewed by Carmen Pope, BPharm. Last updated on May 8, 2025.

Official Answer by Drugs.com

TC is a chemotherapy regimen that combines Taxotere with cyclophosphamide and can be used before or after surgery to treat early-stage or localized breast cancer (breast cancer that hasn’t spread).

Combination chemotherapy, such as TC, usually works better than individual drugs because each agent works in a different way to kill cancer cells and reduce cancer spread.

What drugs are in TC chemotherapy?

The 2 drugs contained in TC are:

Taxotere (also called docetaxel): a taxane that works by disrupting the internal structure of the cell (cytoskeleton), interfering with the ability of cancer cells to divide
Cyclophosphamide (previous brand name Cytoxan): an alkylating agent that damages cancer cell DNA making it impossible for the cancer cells to reproduce.

The complementary mechanisms of action of these two agents means they have a powerful synergistic effect when combined because they:

Target different cellular components (cytoskeleton vs. DNA)
Work at different phases of the cell cycle
Overwhelm the cancer cell’s repair mechanism
Are more likely to overcome resistance that might develop when using either agent alone.

How is TC administered?

TC is usually given once every three weeks (21 days). It will be given intravenously (into your blood stream) by a healthcare provider in an infusion clinic or other medical facility.

Treatment may be given through a long plastic tube that goes into a large vein in your chest, such as a central line, PICC line, or a portacath, if you have one. Otherwise it may be given through a thin short tube (cannula) that goes into your arm or hand.

TC is usually given as cycles of treatment. Each cycle lasts 21 days (3 weeks).

Day 1. Taxotere is given as a drip in your bloodstream over an hour. Cyclophosphamide is given as a slow injection or drip into your vein over about 30 minutes.

Days 2 to 21. No treatment.

Sometimes premedication, such as antinausea treatment, is given before receiving TC.

Most people can expect to be at the clinic for 3 to 4 hours each time they receive TC chemotherapy.

When is TC used in Breast Cancer treatment?

TC is one option to treat early-stage node-negative or low-risk node-positive breast cancer that requires chemotherapy. The most common uses of TC include:

Before surgery (this is called neoadjuvant chemotherapy)
After surgery (this is called adjuvant chemotherapy).

Because TC does not contain an anthracycline, it may be given to breast cancer patients with heart issues, because anthracyclines (such as doxorubicin (Adriamycin) cannot be used in these patients.

When considering what chemotherapy regimen to use, healthcare providers take into account:

How effective the regimen is compared to others. Clinical trials have determined that TC is comparable to AC (doxorubicin/cyclophosphamide) in disease-free and overall survival for early-stage breast cancer
Particular benefits in certain subtypes: TC may offer enhanced effectiveness in certain breast cancer types, particularly HER2- negative populations
Likely toxicities: TC has low cardiac toxicity and is used instead of AC or TAC regimens in breast cancer patients with heart issues, because it doesn’t contain an anthracycline (such as doxorubicin (Adriamycin)
Side effect advantages: Because TC does not contain an anthracycline there is a low risk of secondary leukemias and long-term cardiac damage
Treatment duration and complexity: TC is typically administered in 4 to 6 cycles compared to other regimens like AC-T which requires more cycles and TAC which requires more intensive supportive care and monitoring
Patient selection factors: Higher grade cancers and younger patients may require more aggressive therapy.
Balance of efficacy vs. toxicity: Healthcare providers take into account the risk benefit ratio of chemotherapy regimens.

How effective is TC chemotherapy?

TC chemotherapy is an effective alternative to AC (doxorubicin/cyclophosphamide) chemotherapy in breast cancer treatment. TC demonstrates comparable or superior survival outcomes while avoiding anthracycline-related cardiac toxicity, making it particularly valuable for patients with cardiac risk factors.

The results below were primarily derived from the US Oncology 9735 trial, which provided the strongest direct comparison of TC vs. AC. Subsequent meta-analyses and real-world data have generally supported these findings.

What are the common side effects of TC?

Most side effects from TC are temporary and manageable.

The most common side effects of TC are:

Hair loss
Fatigue
Irregular periods
Low blood counts (low platelets/neutrophils)
Nail changes
Muscle/joint aches
Numbness/tingling in the hands and feet
Reflux or heartburn
Mouth sores
Taste changes.

Less common side effects of TC are:

Swelling in the arms or legs
Diarrhea
Constipation
Nausea
Vomiting
Fever
Infection
Mild infusion reactions.

Rarely, TC may cause bladder damage, secondary blood cancers (such as leukemia), or lung inflammation.

Managing side effects from TC

Allergic reactions

Premedicate with an antihistamine and corticosteroid to reduce risk.

Hair loss

Consider cold caps to cool the scalp during chemotherapy and reduce the amount of chemotherapy reaching the hair follicles.

Infection

Ask your healthcare provider about pegfilgrastim or biosimilar 24-48 hours after chemotherapy to reduce infection risk.
Wash your hands frequently, avoid large crowds, animal waste, or people who are sick.

Swelling, nausea, and vomiting

Dexamethasone taken before, during, and after chemo.

Nausea and vomiting

Antiemetic before chemotherapy.
Antiemetic to take home.

Diarrhea

Loperamide to reduce the frequency of your bowel movements.

Constipation

Laxatives to improve how frequently you go to the toilet.

Peripheral neuropathy

Protect hands/feet from extreme cold.
Wear comfortable nonslip shoes.

Fertility

Talk to your healthcare provider about egg harvesting or sperm banking before you start treatment.

Important considerations during treatment

Avoid immunizations with live vaccines (measles, mumps, BCG) while you are having treatment and for up to 12 months afterwards. Ensure you are up to date with you vaccinations before you start treatment.
Do not become pregnant while having treatment with TC because it may harm your unborn baby. Use effective contraception while you are having treatment and for a year afterwards.
Reduce your risk of infection by washing your hands frequently and staying away from sick people or large crowds.
Do not breastfeed while having TC.

Blood monitoring required before each cycle.

A complete blood count and comprehensive metabolic panel is typically required before the start of each TC cycle to ensure your blood counts have recovered sufficiently before the next treatment.
TC carries a high risk of febrile neutropenia. Your healthcare provide may consider use of pegfilgrastim to reduce this risk.
Keep all your appointments and tell your healthcare team about any side effects you may have.

References

Chemotherapy for Breast Cancer. American Cancer Society. https://www.cancer.org/cancer/types/breast-cancer/treatment/chemotherapy-for-breast-cancer.html
TC Chemotherapy teaching. Mass General Cancer Center. https://www.massgeneral.org/assets/mgh/pdf/cancer-center/breast-cancer/chemotherapy-regimen-tc.pdf
TC Protocol: Taxotere + Cytoxan. BreastCancer.org https://www.breastcancer.org/drugs/TC-chemo
Jones S, Holmes FA, O'Shaughnessy J, Blum JL, Vukelja SJ, McIntyre KJ, Pippen JE, Bordelon JH, Kirby RL, Sandbach J, Hyman WJ, Richards DA, Mennel RG, Boehm KA, Meyer WG, Asmar L, Mackey D, Riedel S, Muss H, Savin MA. Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735. J Clin Oncol. 2009 Mar 10;27(8):1177-83. doi: 10.1200/JCO.2008.18.4028. Epub 2009 Feb 9. PMID: 19204201.
Caparica R, Bruzzone M, Poggio F, Ceppi M, de Azambuja E, Lambertini M. Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials. Breast Cancer Res Treat. 2019 Feb;174(1):27-37. doi: 10.1007/s10549-018-5055-9. Epub 2018 Nov 21. PMID: 30465156.

How do you manage neuropathy from chemo?

Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent and often distressing side effect of cancer treatment that affects the nerves. Common symptoms of CIPN are numbness, tingling, burning pain, and muscle weakness, which often occur in the hands and feet.

What is chemo brain and how long does it last?

Chemo brain, also known as chemotherapy-induced cognitive impairment (CICI), chemo fog, or cancer-related cognitive impairment, refers to the cognitive difficulties experienced by many cancer patients during and after chemotherapy treatment. This condition is characterized by a noticeable decline in mental abilities, including memory, learning, attention, and executive functions such as planning and multitasking.

What is the FLOT chemotherapy regimen and how does it work?

FLOT chemotherapy contains a combination of fluorouracil, leucovorin, oxaliplatin, and docetaxel. It is highly effective for resectable gastroesophageal and gastric adenocarcinomas, offering superior survival and tumor response rates compared to both chemoradiotherapy (CROSS) and older chemotherapy regimens (ECF/ECX).

What is the TC chemo regimen and how does it treat breast cancer?

What drugs are in TC chemotherapy?

How is TC administered?

When is TC used in Breast Cancer treatment?

How effective is TC chemotherapy?

Related questions

Overall Survival (OS)

Disease-Free Survival (DFS)

Recurrence Reduction

Key Considerations